Global Dermatology Drugs for Pets Market Growth 2020-2025


Sep, 2020 | Report ID: 151342 | 137 | Pharmaceuticals and Healthcare

According to this study, over the next five years the Dermatology Drugs for Pets market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Dermatology Drugs for Pets business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Dermatology Drugs for Pets market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Dermatology Drugs for Pets, covering the supply chain analysis, impact assessment to the Dermatology Drugs for Pets market size growth rate in several scenarios, and the measures to be undertaken by Dermatology Drugs for Pets companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.

Antibiotics

Antifungal Drugs

Others

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.

Pets Clinics

Pets Hospitals

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

Bayer Animal Health

Boehringer Ingelheim Vetmedica

Zoetis Inc.

Elanco

Ceva Sante Animale

Vetoquinol S.A.panies

IDEXX Laboratories

Virbac S.A.

Merial

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

To study and analyze the global Dermatology Drugs for Pets consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.

To understand the structure of Dermatology Drugs for Pets market by identifying its various subsegments.

Focuses on the key global Dermatology Drugs for Pets manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Dermatology Drugs for Pets with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the consumption of Dermatology Drugs for Pets submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.


Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Dermatology Drugs for Pets Consumption 2015-2025

2.1.2 Dermatology Drugs for Pets Consumption CAGR by Region

2.2 Dermatology Drugs for Pets Segment by Type

2.2.1 Antibiotics

2.2.2 Antifungal Drugs

2.2.3 Others

2.3 Dermatology Drugs for Pets Consumption by Type

2.3.1 Global Dermatology Drugs for Pets Consumption Market Share by Type (2015-2020)

2.3.2 Global Dermatology Drugs for Pets Revenue and Market Share by Type (2015-2020)

2.3.3 Global Dermatology Drugs for Pets Sale Price by Type (2015-2020)

2.4 Dermatology Drugs for Pets Segment by Application

2.4.1 Pets Clinics

2.4.2 Pets Hospitals

2.4.3 Others

2.5 Dermatology Drugs for Pets Consumption by Application

2.5.1 Global Dermatology Drugs for Pets Consumption Market Share by Type (2015-2020)

2.5.2 Global Dermatology Drugs for Pets Value and Market Share by Type (2015-2020)

2.5.3 Global Dermatology Drugs for Pets Sale Price by Type (2015-2020)

3 Global Dermatology Drugs for Pets by Company

3.1 Global Dermatology Drugs for Pets Sales Market Share by Company

3.1.1 Global Dermatology Drugs for Pets Sales by Company (2018-2020)

3.1.2 Global Dermatology Drugs for Pets Sales Market Share by Company (2018-2020)

3.2 Global Dermatology Drugs for Pets Revenue Market Share by Company

3.2.1 Global Dermatology Drugs for Pets Revenue by Company (2018-2020)

3.2.2 Global Dermatology Drugs for Pets Revenue Market Share by Company (2018-2020)

3.3 Global Dermatology Drugs for Pets Sale Price by Company

3.4 Global Dermatology Drugs for Pets Manufacturing Base Distribution, Sales Area, Type by Company

3.4.1 Global Dermatology Drugs for Pets Manufacturing Base Distribution and Sales Area by Company

3.4.2 Players Dermatology Drugs for Pets Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Dermatology Drugs for Pets by Regions

4.1 Dermatology Drugs for Pets by Regions

4.2 Americas Dermatology Drugs for Pets Consumption Growth

4.3 APAC Dermatology Drugs for Pets Consumption Growth

4.4 Europe Dermatology Drugs for Pets Consumption Growth

4.5 Middle East & Africa Dermatology Drugs for Pets Consumption Growth

5 Americas

5.1 Americas Dermatology Drugs for Pets Consumption by Countries

5.1.1 Americas Dermatology Drugs for Pets Consumption by Countries (2015-2020)

5.1.2 Americas Dermatology Drugs for Pets Value by Countries (2015-2020)

5.2 Americas Dermatology Drugs for Pets Consumption by Type

5.3 Americas Dermatology Drugs for Pets Consumption by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

5.8 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Dermatology Drugs for Pets Consumption by Regions

6.1.1 APAC Dermatology Drugs for Pets Consumption by Regions (2015-2020)

6.1.2 APAC Dermatology Drugs for Pets Value by Regions (2015-2020)

6.2 APAC Dermatology Drugs for Pets Consumption by Type

6.3 APAC Dermatology Drugs for Pets Consumption by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Regions

7 Europe

7.1 Europe Dermatology Drugs for Pets by Countries

7.1.1 Europe Dermatology Drugs for Pets Consumption by Countries (2015-2020)

7.1.2 Europe Dermatology Drugs for Pets Value by Countries (2015-2020)

7.2 Europe Dermatology Drugs for Pets Consumption by Type

7.3 Europe Dermatology Drugs for Pets Consumption by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Dermatology Drugs for Pets by Countries

8.1.1 Middle East & Africa Dermatology Drugs for Pets Consumption by Countries (2015-2020)

8.1.2 Middle East & Africa Dermatology Drugs for Pets Value by Countries (2015-2020)

8.2 Middle East & Africa Dermatology Drugs for Pets Consumption by Type

8.3 Middle East & Africa Dermatology Drugs for Pets Consumption by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Dermatology Drugs for Pets Distributors

10.3 Dermatology Drugs for Pets Customer

11 Global Dermatology Drugs for Pets Market Forecast

11.1 Global Dermatology Drugs for Pets Consumption Forecast (2021-2025)

11.2 Global Dermatology Drugs for Pets Forecast by Regions

11.2.1 Global Dermatology Drugs for Pets Forecast by Regions (2021-2025)

11.2.2 Global Dermatology Drugs for Pets Value Forecast by Regions (2021-2025)

11.2.3 Americas Consumption Forecast

11.2.4 APAC Consumption Forecast

11.2.5 Europe Consumption Forecast

11.2.6 Middle East & Africa Consumption Forecast

11.3 Americas Forecast by Countries

11.3.1 United States Market Forecast

11.3.2 Canada Market Forecast

11.3.3 Mexico Market Forecast

11.3.4 Brazil Market Forecast

11.4 APAC Forecast by Countries

11.4.1 China Market Forecast

11.4.2 Japan Market Forecast

11.4.3 Korea Market Forecast

11.4.4 Southeast Asia Market Forecast

11.4.5 India Market Forecast

11.4.6 Australia Market Forecast

11.5 Europe Forecast by Countries

11.5.1 Germany Market Forecast

11.5.2 France Market Forecast

11.5.3 UK Market Forecast

11.5.4 Italy Market Forecast

11.5.5 Russia Market Forecast

11.6 Middle East & Africa Forecast by Countries

11.6.1 Egypt Market Forecast

11.6.2 South Africa Market Forecast

11.6.3 Israel Market Forecast

11.6.4 Turkey Market Forecast

11.6.5 GCC Countries Market Forecast

11.7 Global Dermatology Drugs for Pets Forecast by Type

11.8 Global Dermatology Drugs for Pets Forecast by Application

12 Key Players Analysis

12.1 Bayer Animal Health

12.1.1 Company Information

12.1.2 Dermatology Drugs for Pets Product Offered

12.1.3 Bayer Animal Health Dermatology Drugs for Pets Sales, Revenue, Price and Gross Margin (2018-2020)

12.1.4 Main Business Overview

12.1.5 Bayer Animal Health Latest Developments

12.2 Boehringer Ingelheim Vetmedica

12.2.1 Company Information

12.2.2 Dermatology Drugs for Pets Product Offered

12.2.3 Boehringer Ingelheim Vetmedica Dermatology Drugs for Pets Sales, Revenue, Price and Gross Margin (2018-2020)

12.2.4 Main Business Overview

12.2.5 Boehringer Ingelheim Vetmedica Latest Developments

12.3 Zoetis Inc.

12.3.1 Company Information

12.3.2 Dermatology Drugs for Pets Product Offered

12.3.3 Zoetis Inc. Dermatology Drugs for Pets Sales, Revenue, Price and Gross Margin (2018-2020)

12.3.4 Main Business Overview

12.3.5 Zoetis Inc. Latest Developments

12.4 Elanco

12.4.1 Company Information

12.4.2 Dermatology Drugs for Pets Product Offered

12.4.3 Elanco Dermatology Drugs for Pets Sales, Revenue, Price and Gross Margin (2018-2020)

12.4.4 Main Business Overview

12.4.5 Elanco Latest Developments

12.5 Ceva Sante Animale

12.5.1 Company Information

12.5.2 Dermatology Drugs for Pets Product Offered

12.5.3 Ceva Sante Animale Dermatology Drugs for Pets Sales, Revenue, Price and Gross Margin (2018-2020)

12.5.4 Main Business Overview

12.5.5 Ceva Sante Animale Latest Developments

12.6 Vetoquinol S.A.panies

12.6.1 Company Information

12.6.2 Dermatology Drugs for Pets Product Offered

12.6.3 Vetoquinol S.A.panies Dermatology Drugs for Pets Sales, Revenue, Price and Gross Margin (2018-2020)

12.6.4 Main Business Overview

12.6.5 Vetoquinol S.A.panies Latest Developments

12.7 IDEXX Laboratories

12.7.1 Company Information

12.7.2 Dermatology Drugs for Pets Product Offered

12.7.3 IDEXX Laboratories Dermatology Drugs for Pets Sales, Revenue, Price and Gross Margin (2018-2020)

12.7.4 Main Business Overview

12.7.5 IDEXX Laboratories Latest Developments

12.8 Virbac S.A.

12.8.1 Company Information

12.8.2 Dermatology Drugs for Pets Product Offered

12.8.3 Virbac S.A. Dermatology Drugs for Pets Sales, Revenue, Price and Gross Margin (2018-2020)

12.8.4 Main Business Overview

12.8.5 Virbac S.A. Latest Developments

12.9 Merial

12.9.1 Company Information

12.9.2 Dermatology Drugs for Pets Product Offered

12.9.3 Merial Dermatology Drugs for Pets Sales, Revenue, Price and Gross Margin (2018-2020)

12.9.4 Main Business Overview

12.9.5 Merial Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology

Table 2. Data Source

Table 3. Dermatology Drugs for Pets Consumption CAGR by Region 2015-2025 ($ Millions)

Table 4. Major Players of Antibiotics

Table 5. Major Players of Antifungal Drugs

Table 6. Major Players of Others

Table 7. Global Consumption Sales by Type (2015-2020)

Table 8. Global Dermatology Drugs for Pets Consumption Market Share by Type (2015-2020)

Table 9. Global Dermatology Drugs for Pets Revenue by Type (2015-2020) ($ million)

Table 10. Global Dermatology Drugs for Pets Value Market Share by Type (2015-2020) ($ Millions)

Table 11. Global Dermatology Drugs for Pets Sale Price by Type (2015-2020)

Table 12. Global Consumption Sales by Application (2015-2020)

Table 13. Global Dermatology Drugs for Pets Consumption Market Share by Application (2015-2020)

Table 14. Global Dermatology Drugs for Pets Value by Application (2015-2020)

Table 15. Global Dermatology Drugs for Pets Value Market Share by Application (2015-2020)

Table 16. Global Dermatology Drugs for Pets Sale Price by Application (2015-2020)

Table 17. Global Dermatology Drugs for Pets Sales by Company (2017-2019) (K Units)

Table 18. Global Dermatology Drugs for Pets Sales Market Share by Company (2017-2019)

Table 19. Global Dermatology Drugs for Pets Revenue by Company (2017-2019) ($ Millions)

Table 20. Global Dermatology Drugs for Pets Revenue Market Share by Company (2017-2019)

Table 21. Global Dermatology Drugs for Pets Sale Price by Company (2017-2019)

Table 22. Global Dermatology Drugs for Pets Manufacturing Base Distribution and Sales Area by Manufacturers

Table 23. Players Dermatology Drugs for Pets Products Offered

Table 24. Dermatology Drugs for Pets Concentration Ratio (CR3, CR5 and CR10) (2017-2019)

Table 25. Global Dermatology Drugs for Pets Consumption by Regions 2015-2020 (K Units)

Table 26. Global Dermatology Drugs for Pets Consumption Market Share by Regions 2015-2020

Table 27. Global Dermatology Drugs for Pets Value by Regions 2015-2020 ($ Millions)

Table 28. Global Dermatology Drugs for Pets Value Market Share by Regions 2015-2020

Table 29. Americas Dermatology Drugs for Pets Consumption by Countries (2015-2020) (K Units)

Table 30. Americas Dermatology Drugs for Pets Consumption Market Share by Countries (2015-2020)

Table 31. Americas Dermatology Drugs for Pets Value by Countries (2015-2020) ($ Millions)

Table 32. Americas Dermatology Drugs for Pets Value Market Share by Countries (2015-2020)

Table 33. Americas Dermatology Drugs for Pets Consumption by Type (2015-2020) (K Units)

Table 34. Americas Dermatology Drugs for Pets Consumption Market Share by Type (2015-2020)

Table 35. Americas Dermatology Drugs for Pets Consumption by Application (2015-2020) (K Units)

Table 36. Americas Dermatology Drugs for Pets Consumption Market Share by Application (2015-2020)

Table 37. APAC Dermatology Drugs for Pets Consumption by Countries (2015-2020) (K Units)

Table 38. APAC Dermatology Drugs for Pets Consumption Market Share by Countries (2015-2020)

Table 39. APAC Dermatology Drugs for Pets Value by Regions (2015-2020) ($ Millions)

Table 40. APAC Dermatology Drugs for Pets Value Market Share by Regions (2015-2020)

Table 41. APAC Dermatology Drugs for Pets Consumption by Type (2015-2020) (K Units)

Table 42. APAC Dermatology Drugs for Pets Consumption Market Share by Type (2015-2020)

Table 43. APAC Dermatology Drugs for Pets Consumption by Application (2015-2020) (K Units)

Table 44. APAC Dermatology Drugs for Pets Consumption Market Share by Application (2015-2020)

Table 45. Europe Dermatology Drugs for Pets Consumption by Countries (2015-2020) (K Units)

Table 46. Europe Dermatology Drugs for Pets Consumption Market Share by Countries (2015-2020)

Table 47. Europe Dermatology Drugs for Pets Value by Countries (2015-2020) ($ Millions)

Table 48. Europe Dermatology Drugs for Pets Value Market Share by Countries (2015-2020)

Table 49. Europe Dermatology Drugs for Pets Consumption by Type (2015-2020) (K Units)

Table 50. Europe Dermatology Drugs for Pets Consumption Market Share by Type (2015-2020)

Table 51. Europe Dermatology Drugs for Pets Consumption by Application (2015-2020) (K Units)

Table 52. Europe Dermatology Drugs for Pets Consumption Market Share by Application (2015-2020)

Table 53. Middle East & Africa Dermatology Drugs for Pets Consumption by Countries (2015-2020) (K Units)

Table 54. Middle East & Africa Dermatology Drugs for Pets Consumption Market Share by Countries (2015-2020)

Table 55. Middle East & Africa Dermatology Drugs for Pets Value by Countries (2015-2020) ($ Millions)

Table 56. Middle East & Africa Dermatology Drugs for Pets Value Market Share by Countries (2015-2020)

Table 57. Middle East & Africa Dermatology Drugs for Pets Consumption by Type (2015-2020) (K Units)

Table 58. Middle East & Africa Dermatology Drugs for Pets Consumption Market Share by Type (2015-2020)

Table 59. Middle East & Africa Dermatology Drugs for Pets Consumption by Application (2015-2020) (K Units)

Table 60. Middle East & Africa Dermatology Drugs for Pets Consumption Market Share by Application (2015-2020)

Table 61. Dermatology Drugs for Pets Distributors List

Table 62. Dermatology Drugs for Pets Customer List

Table 63. Global Dermatology Drugs for Pets Consumption Forecast by Countries (2021-2025) (K Units)

Table 64. Global Dermatology Drugs for Pets Consumption Market Forecast by Regions

Table 65. Global Dermatology Drugs for Pets Value Forecast by Countries (2021-2025) ($ Millions)

Table 66. Global Dermatology Drugs for Pets Value Market Share Forecast by Regions

Table 67. Global Dermatology Drugs for Pets Consumption Forecast by Type (2021-2025) (K Units)

Table 68. Global Dermatology Drugs for Pets Consumption Market Share Forecast by Type (2021-2025)

Table 69. Global Dermatology Drugs for Pets Value Forecast by Type (2021-2025) ($ Millions)

Table 70. Global Dermatology Drugs for Pets Value Market Share Forecast by Type (2021-2025)

Table 71. Global Dermatology Drugs for Pets Consumption Forecast by Application (2021-2025) (K Units)

Table 72. Global Dermatology Drugs for Pets Consumption Market Share Forecast by Application (2021-2025)

Table 73. Global Dermatology Drugs for Pets Value Forecast by Application (2021-2025) ($ Millions)

Table 74. Global Dermatology Drugs for Pets Value Market Share Forecast by Application (2021-2025)

Table 75. Bayer Animal Health Product Offered

Table 76. Bayer Animal Health Dermatology Drugs for Pets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 77. Bayer Animal Health Main Business

Table 78. Bayer Animal Health Latest Developments

Table 79. Bayer Animal Health Basic Information, Company Total Revenue (in $ million), Dermatology Drugs for Pets Manufacturing Base, Sales Area and Its Competitors

Table 80. Boehringer Ingelheim Vetmedica Product Offered

Table 81. Boehringer Ingelheim Vetmedica Dermatology Drugs for Pets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 82. Boehringer Ingelheim Vetmedica Main Business

Table 83. Boehringer Ingelheim Vetmedica Latest Developments

Table 84. Boehringer Ingelheim Vetmedica Basic Information, Company Total Revenue (in $ million), Dermatology Drugs for Pets Manufacturing Base, Sales Area and Its Competitors

Table 85. Zoetis Inc. Product Offered

Table 86. Zoetis Inc. Dermatology Drugs for Pets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 87. Zoetis Inc. Main Business

Table 88. Zoetis Inc. Latest Developments

Table 89. Zoetis Inc. Basic Information, Company Total Revenue (in $ million), Dermatology Drugs for Pets Manufacturing Base, Sales Area and Its Competitors

Table 90. Elanco Product Offered

Table 91. Elanco Dermatology Drugs for Pets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 92. Elanco Main Business

Table 93. Elanco Latest Developments

Table 94. Elanco Basic Information, Company Total Revenue (in $ million), Dermatology Drugs for Pets Manufacturing Base, Sales Area and Its Competitors

Table 95. Ceva Sante Animale Product Offered

Table 96. Ceva Sante Animale Dermatology Drugs for Pets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 97. Ceva Sante Animale Main Business

Table 98. Ceva Sante Animale Latest Developments

Table 99. Ceva Sante Animale Basic Information, Company Total Revenue (in $ million), Dermatology Drugs for Pets Manufacturing Base, Sales Area and Its Competitors

Table 100. Vetoquinol S.A.panies Product Offered

Table 101. Vetoquinol S.A.panies Dermatology Drugs for Pets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 102. Vetoquinol S.A.panies Main Business

Table 103. Vetoquinol S.A.panies Latest Developments

Table 104. Vetoquinol S.A.panies Basic Information, Company Total Revenue (in $ million), Dermatology Drugs for Pets Manufacturing Base, Sales Area and Its Competitors

Table 105. IDEXX Laboratories Product Offered

Table 106. IDEXX Laboratories Basic Information, Company Total Revenue (in $ million), Dermatology Drugs for Pets Manufacturing Base, Sales Area and Its Competitors

Table 107. IDEXX Laboratories Main Business

Table 108. IDEXX Laboratories Latest Developments

Table 109. IDEXX Laboratories Dermatology Drugs for Pets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 110. Virbac S.A. Product Offered

Table 111. Virbac S.A. Dermatology Drugs for Pets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 112. Virbac S.A. Main Business

Table 113. Virbac S.A. Latest Developments

Table 114. Virbac S.A. Basic Information, Company Total Revenue (in $ million), Dermatology Drugs for Pets Manufacturing Base, Sales Area and Its Competitors

Table 115. Merial Product Offered

Table 116. Merial Dermatology Drugs for Pets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 117. Merial Main Business

Table 118. Merial Latest Developments

Table 119. Merial Basic Information, Company Total Revenue (in $ million), Dermatology Drugs for Pets Manufacturing Base, Sales Area and Its Competitors

List of Figures

Figure 1. Picture of Dermatology Drugs for Pets

Figure 2. Dermatology Drugs for Pets Report Years Considered

Figure 3. Market Research Methodology

Figure 4. Global Dermatology Drugs for Pets Consumption Growth Rate 2015-2025 (K Units)

Figure 5. Global Dermatology Drugs for Pets Value Growth Rate 2015-2025 ($ Millions)

Figure 6. Product Picture of Antibiotics

Figure 7. Product Picture of Antifungal Drugs

Figure 8. Product Picture of Others

Figure 9. Global Dermatology Drugs for Pets Consumption Market Share by Type (2015-2020)

Figure 10. Global Dermatology Drugs for Pets Value Market Share by Type (2015-2020)

Figure 11. Dermatology Drugs for Pets Consumed in Pets Clinics

Figure 12. Global Dermatology Drugs for Pets Market: Pets Clinics (2015-2020) (K Units)

Figure 13. Global Dermatology Drugs for Pets Market: Pets Clinics (2015-2020) ($ Millions)

Figure 14. Dermatology Drugs for Pets Consumed in Pets Hospitals

Figure 15. Global Dermatology Drugs for Pets Market: Pets Hospitals (2015-2020) (K Units)

Figure 16. Global Dermatology Drugs for Pets Market: Pets Hospitals (2015-2020) ($ Millions)

Figure 17. Dermatology Drugs for Pets Consumed in Others

Figure 18. Global Dermatology Drugs for Pets Market: Others (2015-2020) (K Units)

Figure 19. Global Dermatology Drugs for Pets Market: Others (2015-2020) ($ Millions)

Figure 20. Global Dermatology Drugs for Pets Consumption Market Share by Application (2015-2020)

Figure 21. Global Dermatology Drugs for Pets Value Market Share by Application (2015-2020)

Figure 22. Global Dermatology Drugs for Pets Sales Market Share by Company in 2017

Figure 23. Global Dermatology Drugs for Pets Sales Market Share by Company in 2019

Figure 24. Global Dermatology Drugs for Pets Revenue Market Share by Company in 2017

Figure 25. Global Dermatology Drugs for Pets Revenue Market Share by Company in 2019

Figure 26. Global Dermatology Drugs for Pets Sale Price by Company in 2019

Figure 27. Global Dermatology Drugs for Pets Consumption Market Share by Regions 2015-2020

Figure 28. Global Dermatology Drugs for Pets Value Market Share by Regions 2015-2020

Figure 29. Americas Dermatology Drugs for Pets Consumption 2015-2020 (K Units)

Figure 30. Americas Dermatology Drugs for Pets Value 2015-2020 ($ Millions)

Figure 31. APAC Dermatology Drugs for Pets Consumption 2015-2020 (K Units)

Figure 32. APAC Dermatology Drugs for Pets Value 2015-2020 ($ Millions)

Figure 33. Europe Dermatology Drugs for Pets Consumption 2015-2020 (K Units)

Figure 34. Europe Dermatology Drugs for Pets Value 2015-2020 ($ Millions)

Figure 35. Middle East & Africa Dermatology Drugs for Pets Consumption 2015-2020 (K Units)

Figure 36. Middle East & Africa Dermatology Drugs for Pets Value 2015-2020 ($ Millions)

Figure 37. Americas Dermatology Drugs for Pets Consumption Market Share by Countries in 2019

Figure 38. Americas Dermatology Drugs for Pets Value Market Share by Countries in 2019

Figure 39. Americas Dermatology Drugs for Pets Consumption Market Share by Type in 2019

Figure 40. Americas Dermatology Drugs for Pets Consumption Market Share by Application in 2019

Figure 41. United States Dermatology Drugs for Pets Consumption Growth 2015-2020 (K Units)

Figure 42. United States Dermatology Drugs for Pets Value Growth 2015-2020 ($ Millions)

Figure 43. Canada Dermatology Drugs for Pets Consumption Growth 2015-2020 (K Units)

Figure 44. Canada Dermatology Drugs for Pets Value Growth 2015-2020 ($ Millions)

Figure 45. Mexico Dermatology Drugs for Pets Consumption Growth 2015-2020 (K Units)

Figure 46. Mexico Dermatology Drugs for Pets Value Growth 2015-2020 ($ Millions)

Figure 47. APAC Dermatology Drugs for Pets Consumption Market Share by Countries in 2019

Figure 48. APAC Dermatology Drugs for Pets Value Market Share by Regions in 2019

Figure 49. APAC Dermatology Drugs for Pets Consumption Market Share by Type in 2019

Figure 50. APAC Dermatology Drugs for Pets Consumption Market Share by Application in 2019

Figure 51. China Dermatology Drugs for Pets Consumption Growth 2015-2020 (K Units)

Figure 52. China Dermatology Drugs for Pets Value Growth 2015-2020 ($ Millions)

Figure 53. Japan Dermatology Drugs for Pets Consumption Growth 2015-2020 (K Units)

Figure 54. Japan Dermatology Drugs for Pets Value Growth 2015-2020 ($ Millions)

Figure 55. Korea Dermatology Drugs for Pets Consumption Growth 2015-2020 (K Units)

Figure 56. Korea Dermatology Drugs for Pets Value Growth 2015-2020 ($ Millions)

Figure 57. Southeast Asia Dermatology Drugs for Pets Consumption Growth 2015-2020 (K Units)

Figure 58. Southeast Asia Dermatology Drugs for Pets Value Growth 2015-2020 ($ Millions)

Figure 59. India Dermatology Drugs for Pets Consumption Growth 2015-2020 (K Units)

Figure 60. India Dermatology Drugs for Pets Value Growth 2015-2020 ($ Millions)

Figure 61. Australia Dermatology Drugs for Pets Consumption Growth 2015-2020 (K Units)

Figure 62. Australia Dermatology Drugs for Pets Value Growth 2015-2020 ($ Millions)

Figure 63. Europe Dermatology Drugs for Pets Consumption Market Share by Countries in 2019

Figure 64. Europe Dermatology Drugs for Pets Value Market Share by Countries in 2019

Figure 65. Europe Dermatology Drugs for Pets Consumption Market Share by Type in 2019

Figure 66. Europe Dermatology Drugs for Pets Consumption Market Share by Application in 2019

Figure 67. Germany Dermatology Drugs for Pets Consumption Growth 2015-2020 (K Units)

Figure 68. Germany Dermatology Drugs for Pets Value Growth 2015-2020 ($ Millions)

Figure 69. France Dermatology Drugs for Pets Consumption Growth 2015-2020 (K Units)

Figure 70. France Dermatology Drugs for Pets Value Growth 2015-2020 ($ Millions)

Figure 71. UK Dermatology Drugs for Pets Consumption Growth 2015-2020 (K Units)

Figure 72. UK Dermatology Drugs for Pets Value Growth 2015-2020 ($ Millions)

Figure 73. Italy Dermatology Drugs for Pets Consumption Growth 2015-2020 (K Units)

Figure 74. Italy Dermatology Drugs for Pets Value Growth 2015-2020 ($ Millions)

Figure 75. Russia Dermatology Drugs for Pets Consumption Growth 2015-2020 (K Units)

Figure 76. Russia Dermatology Drugs for Pets Value Growth 2015-2020 ($ Millions)

Figure 77. Middle East & Africa Dermatology Drugs for Pets Consumption Market Share by Countries in 2019

Figure 78. Middle East & Africa Dermatology Drugs for Pets Value Market Share by Countries in 2019

Figure 79. Middle East & Africa Dermatology Drugs for Pets Consumption Market Share by Type in 2019

Figure 80. Middle East & Africa Dermatology Drugs for Pets Consumption Market Share by Application in 2019

Figure 81. Egypt Dermatology Drugs for Pets Consumption Growth 2015-2020 (K Units)

Figure 82. Egypt Dermatology Drugs for Pets Value Growth 2015-2020 ($ Millions)

Figure 83. South Africa Dermatology Drugs for Pets Consumption Growth 2015-2020 (K Units)

Figure 84. South Africa Dermatology Drugs for Pets Value Growth 2015-2020 ($ Millions)

Figure 85. Israel Dermatology Drugs for Pets Consumption Growth 2015-2020 (K Units)

Figure 86. Israel Dermatology Drugs for Pets Value Growth 2015-2020 ($ Millions)

Figure 87. Turkey Dermatology Drugs for Pets Consumption Growth 2015-2020 (K Units)

Figure 88. Turkey Dermatology Drugs for Pets Value Growth 2015-2020 ($ Millions)

Figure 89. GCC Countries Dermatology Drugs for Pets Consumption Growth 2015-2020 (K Units)

Figure 90. GCC Countries Dermatology Drugs for Pets Value Growth 2015-2020 ($ Millions)

Figure 91. Global Dermatology Drugs for Pets Consumption Growth Rate Forecast (2021-2025) (K Units)

Figure 92. Global Dermatology Drugs for Pets Value Growth Rate Forecast (2021-2025) ($ Millions)

Figure 93. Americas Dermatology Drugs for Pets Consumption 2021-2025 (K Units)

Figure 94. Americas Dermatology Drugs for Pets Value 2021-2025 ($ Millions)

Figure 95. APAC Dermatology Drugs for Pets Consumption 2021-2025 (K Units)

Figure 96. APAC Dermatology Drugs for Pets Value 2021-2025 ($ Millions)

Figure 97. Europe Dermatology Drugs for Pets Consumption 2021-2025 (K Units)

Figure 98. Europe Dermatology Drugs for Pets Value 2021-2025 ($ Millions)

Figure 99. Middle East & Africa Dermatology Drugs for Pets Consumption 2021-2025 (K Units)

Figure 100. Middle East & Africa Dermatology Drugs for Pets Value 2021-2025 ($ Millions)

Figure 101. United States Dermatology Drugs for Pets Consumption 2021-2025 (K Units)

Figure 102. United States Dermatology Drugs for Pets Value 2021-2025 ($ Millions)

Figure 103. Canada Dermatology Drugs for Pets Consumption 2021-2025 (K Units)

Figure 104. Canada Dermatology Drugs for Pets Value 2021-2025 ($ Millions)

Figure 105. Mexico Dermatology Drugs for Pets Consumption 2021-2025 (K Units)

Figure 106. Mexico Dermatology Drugs for Pets Value 2021-2025 ($ Millions)

Figure 107. Brazil Dermatology Drugs for Pets Consumption 2021-2025 (K Units)

Figure 108. Brazil Dermatology Drugs for Pets Value 2021-2025 ($ Millions)

Figure 109. China Dermatology Drugs for Pets Consumption 2021-2025 (K Units)

Figure 110. China Dermatology Drugs for Pets Value 2021-2025 ($ Millions)

Figure 111. Japan Dermatology Drugs for Pets Consumption 2021-2025 (K Units)

Figure 112. Japan Dermatology Drugs for Pets Value 2021-2025 ($ Millions)

Figure 113. Korea Dermatology Drugs for Pets Consumption 2021-2025 (K Units)

Figure 114. Korea Dermatology Drugs for Pets Value 2021-2025 ($ Millions)

Figure 115. Southeast Asia Dermatology Drugs for Pets Consumption 2021-2025 (K Units)

Figure 116. Southeast Asia Dermatology Drugs for Pets Value 2021-2025 ($ Millions)

Figure 117. India Dermatology Drugs for Pets Consumption 2021-2025 (K Units)

Figure 118. India Dermatology Drugs for Pets Value 2021-2025 ($ Millions)

Figure 119. Australia Dermatology Drugs for Pets Consumption 2021-2025 (K Units)

Figure 120. Australia Dermatology Drugs for Pets Value 2021-2025 ($ Millions)

Figure 121. Germany Dermatology Drugs for Pets Consumption 2021-2025 (K Units)

Figure 122. Germany Dermatology Drugs for Pets Value 2021-2025 ($ Millions)

Figure 123. France Dermatology Drugs for Pets Consumption 2021-2025 (K Units)

Figure 124. France Dermatology Drugs for Pets Value 2021-2025 ($ Millions)

Figure 125. UK Dermatology Drugs for Pets Consumption 2021-2025 (K Units)

Figure 126. UK Dermatology Drugs for Pets Value 2021-2025 ($ Millions)

Figure 127. Italy Dermatology Drugs for Pets Consumption 2021-2025 (K Units)

Figure 128. Italy Dermatology Drugs for Pets Value 2021-2025 ($ Millions)

Figure 129. Russia Dermatology Drugs for Pets Consumption 2021-2025 (K Units)

Figure 130. Russia Dermatology Drugs for Pets Value 2021-2025 ($ Millions)

Figure 131. Spain Dermatology Drugs for Pets Consumption 2021-2025 (K Units)

Figure 132. Spain Dermatology Drugs for Pets Value 2021-2025 ($ Millions)

Figure 133. Egypt Dermatology Drugs for Pets Consumption 2021-2025 (K Units)

Figure 134. Egypt Dermatology Drugs for Pets Value 2021-2025 ($ Millions)

Figure 135. South Africa Dermatology Drugs for Pets Consumption 2021-2025 (K Units)

Figure 136. South Africa Dermatology Drugs for Pets Value 2021-2025 ($ Millions)

Figure 137. Israel Dermatology Drugs for Pets Consumption 2021-2025 (K Units)

Figure 138. Israel Dermatology Drugs for Pets Value 2021-2025 ($ Millions)

Figure 139. Turkey Dermatology Drugs for Pets Consumption 2021-2025 (K Units)

Figure 140. Turkey Dermatology Drugs for Pets Value 2021-2025 ($ Millions)

Figure 141. GCC Countries Dermatology Drugs for Pets Consumption 2021-2025 (K Units)

Figure 142. GCC Countries Dermatology Drugs for Pets Value 2021-2025 ($ Millions)

Figure 143. Bayer Animal Health Dermatology Drugs for Pets Market Share (2018-2020)

Figure 144. Boehringer Ingelheim Vetmedica Dermatology Drugs for Pets Market Share (2018-2020)

Figure 145. Zoetis Inc. Dermatology Drugs for Pets Market Share (2018-2020)

Figure 146. Elanco Dermatology Drugs for Pets Market Share (2018-2020)

Figure 147. Ceva Sante Animale Dermatology Drugs for Pets Market Share (2018-2020)

Figure 148. Vetoquinol S.A.panies Dermatology Drugs for Pets Market Share (2018-2020)

Figure 149. IDEXX Laboratories Dermatology Drugs for Pets Market Share (2018-2020)

Figure 150. Virbac S.A. Dermatology Drugs for Pets Market Share (2018-2020)

Figure 151. Merial Dermatology Drugs for Pets Market Share (2018-2020)

Sample Request is not available